Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs

Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs

Immunotherapy has emerged as an alternative strategy to treat malignancies in addition to conventional radio- and chemotherapy. There has been a plethora of evidence that the immune system is able to control tumor outgrowth and a number of strategies have been put forward to utilize this ability for...

Full description

Bibliographic Details
Main Authors: Slava Stamova, Stefanie Koristka, Juliane Keil, Claudia Arndt, Anja Feldmann, Irene Michalk, Holger Bartsch, Claudia C. Bippes, Marc Schmitz, Marc Cartellieri, Michael Bachmann
Format: Article
Language:English
Published: MDPI AG 2012-07-01
Series:Antibodies
Subjects:
cancer immunotherapy
monoclonal antibodies
antibody engineering
bispecific antibodies
Online Access:http://www.mdpi.com/2073-4468/1/2/172

Internet

http://www.mdpi.com/2073-4468/1/2/172

Similar Items